ZHYBF'
s EV-to-EBIT Range Over the Past 10 Years
Min: -37648.83 Med: -179.09 Max: -13.33
Current: -360.44
During the past 8 years, the highest EV-to-EBIT of Zhong Yuan Bio-Technology Holdings was -13.33. The lowest was -37648.83. And the median was -179.09.
ZHYBF's EV-to-EBIT is ranked worse than 100% of 1470
companies
in the Consumer Packaged Goods industry
Industry Median: 14.055
vs ZHYBF: -360.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zhong Yuan Bio-Technology Holdings's EV-to-EBIT
For the Packaged Foods subindustry, Zhong Yuan Bio-Technology Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhong Yuan Bio-Technology Holdings's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Zhong Yuan Bio-Technology Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Zhong Yuan Bio-Technology Holdings's EV-to-EBIT falls into.
Zhong Yuan Bio-Technology Holdings's current Enterprise Value is $95.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Zhong Yuan Bio-Technology Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Zhong Yuan Bio-Technology Holdings's Enterprise Value for the quarter that ended in Sep. 2023 was $87.09 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Zhong Yuan Bio-Technology Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhong Yuan Bio-Technology Holdings EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description
Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZHYBF has been successfully added to your 